*Higher start in sight after overnight strength in global equities. *AI-theme receives a boost from Baidu's chip unit IPO. *Quiet week of data wrapping up. The stock market finished 2025 on a weak ...
The FDA has approved inebilizumab-cdon (Uplizna, Amgen) for adults with anti-acetylcholine receptor and anti-muscle specific tyrosine kinase antibody positive generalized myasthenia gravis, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback